Isolation of an Extensively Drug-Resistant Pseudomonas aeruginosa <i>exoS</i> <sup>+</sup> /O4 Strain Belonging to the “High-Risk” Clone ST654 and Coproducer of NDM-1 and the Novel VIM-80-Reference-Cited by-同舟云学术

Isolation of an Extensively Drug-Resistant Pseudomonas aeruginosa exoS ⁺ /O4 Strain Belonging to the “High-Risk” Clone ST654 and Coproducer of NDM-1 and the Novel VIM-80

Published:2022-10-26 Issue:5 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Opazo-Capurro Andrés¹²^ORCID,Morales-León Felipe¹²³,Jerez Christian¹⁴,Olivares-Pacheco Jorge²⁵,Alcalde-Rico Manuel²⁵,González-Muñoz Paulina¹⁶,Bello-Toledo Helia¹²^ORCID,Cardenas-Arias Adriana⁷,Esposito Fernanda⁸,Lincopán Nilton⁷⁸^ORCID,Illesca Vijna⁹,González-Rocha Gerardo¹²^ORCID

Affiliation:

1. Laboratorio de Antibióticos, Departamento de Microbiología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile

2. Millennium Nucleus for Collaborative Research on Bacterial Resistance, Santiago, Chile

3. Departamento de Farmacia, Facultad de Farmacia, Universidad de Concepción, Concepción, Chile

4. Department of Restorative School of Dentistry, University of Concepción, Concepción, Chile

5. Grupo de Resistencia Antibacteriana en Bacterias Patógenas Ambientales GRABPA, Instituto de Biología, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile

6. Departamento de Ciencias Biológicas y Químicas, Facultad de Medicina y Ciencia, Universidad San Sebastián, Concepción, Chile

7. Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

8. Department of Clinical Analysis, School of Pharmacy, University of São Paulo, São Paulo, Brazil

9. Hospital Hernán Henríquez Aravena, Clinical Laboratory, Temuco, Chile

Abstract

The aim of this study was to investigate the genomic features of an extensively drug-resistant (XDR) Pseudomonas aeruginosa isolate (P-469) emerging in Chile. Antibiotic susceptibility was determined by disk diffusion and “colistin agar” test.

Funder

ANID | Fondo Nacional de Desarrollo Científico y Tecnológico

Pfizer

Agencia Nacional de Investigación y Desarrollo

Fundação de Amparo à Pesquisa do Estado de São Paulo

PND/CAPES

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.01439-22

Reference9 articles.

1. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update

2. Mobile Carbapenemase Genes in Pseudomonas aeruginosa

3. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

4. Clinical & Laboratory Standards Institute (CLSI). 2021. Performance standards for antimicrobial susceptibility testing. 31st ed. CLSI supplement M100. Clinical & Laboratory Standards Institute, PA, USA.

5. Genetic analysis of the first mcr-1 positive Escherichia coli isolate collected from an outpatient in Chile

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic and Phylogenomic Characterization of Carbapenem-resistant Pseudomonas aeruginosa ‘High-risk’ Clone O4/ExoS+/ST654 Circulating in Chilean Hospitals;Journal of Global Antimicrobial Resistance;2024-09

2. Metallo-beta-lactamase blaNDM-1 in extremely drug-resistant high-risk Pseudomonas aeruginosa clone ST235 and non–high-risk clone ST2407 in Brazil;Journal of Global Antimicrobial Resistance;2024-09

3. Genomic insights into NDM-1-producing Pseudomonas aeruginosa: Current status in a Bulgarian tertiary hospital and on the Balkans;Acta Microbiologica et Immunologica Hungarica;2024-07-02

4. First Detection and Molecular Characterization of Pseudomonas aeruginosa blaNDM-1 ST308 in Greece;Microorganisms;2023-08-26